Gita Vita Soraya

Dr. Gita Vita Soraya


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
Zulvikar UlhaqZulvikar Ulhaq
Zulvikar Ulhaq
GSGita Vita Soraya
Gita Vita Soraya

1 August 2020 in Medicina Clinica
Verified
Journal Article
Closed access
GSGita Vita Soraya
Gita Vita Soraya
Zulvikar UlhaqZulvikar Ulhaq
Zulvikar Ulhaq

23 April 2020 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Open access
PDF file
Zulvikar UlhaqZulvikar Ulhaq
Zulvikar Ulhaq
GSGita Vita Soraya
Gita Vita Soraya

15 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Zulvikar UlhaqZulvikar Ulhaq
Zulvikar Ulhaq
GSGita Vita Soraya
Gita Vita Soraya
BUBudu
Budu
LWLely Retno Wulandari
Lely Retno Wulandari
Interleukin-6 (IL-6) is one of the key regulators behind the inflammatory and pathological process associated with ophthalmic diseases. The role of IL-6-174 G/C polymorphism as well as intraocular IL-6 levels among various eye disease patients differ across studies and has not been systematically reviewed. Thus, this study aims to provide a summary to understand the relationship between IL-6 and ophthalmic disease. In total, 8,252 and 11,014 subjects for IL-6-174 G/C and intraocular levels of IL-6, respectively, were retrieved from PubMed, Scopus and Web of Science. No association was found between IL-6-174 G/C polymorphisms with ocular diseases. Subgroup analyses revealed a suggestive association between the GC genotype of IL-6-174 G/C with proliferative diabetic retinopathy (PDR). Further, the level of intraocular IL-6 among ocular disease patients in general was found to be higher than the control group [standardized mean difference (SMD) = 1.41, 95% confidence interval (CI) 1.24–1.58, P < 0.00001]. Closer examination through subgroup analyses yielded similar results in several ocular diseases. This study thus indicates that the IL-6-174 G/C polymorphism does not predispose patients to ocular disease, although the GC genotype is likely to be a genetic biomarker for PDR. Moreover, intraocular IL-6 concentrations are related to the specific manifestations of the ophthalmic diseases. Further studies with larger sample sizes are warranted to confirm this conclusion.

14 January 2022 in World Journal of Gastroenterology
Verified
Journal Article
Open access
RLRusdina Bte Ladju
Rusdina Bte Ladju
ZUZulvikar Syambani Ulhaq
Zulvikar Syambani Ulhaq
GSGita Vita Soraya
Gita Vita Soraya
Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma

17 October 2022 in Clinical Genetics
Verified
Journal Article
Closed access
Zulvikar UlhaqZulvikar Ulhaq
Zulvikar Ulhaq
DNDian Kesumapramudya Nurputra
Dian Kesumapramudya Nurputra
GSGita Vita Soraya
Gita Vita Soraya
SKSiti Kurniawati
Siti Kurniawati
LILola Ayu Istifiani
Lola Ayu Istifiani
KTKa Fai William Tse
Ka Fai William Tse